MedPath

DEXA Bone Density Analysis of the CoreHip® Prosthesis System

Not Applicable
Not yet recruiting
Conditions
Primary Osteoarthritis
Cartilage Degeneration
Osteoarthritis, Hip
Inflammatory Arthritis
Osteonecrosis of Femoral Head
Traumatic Disorder
Interventions
Device: Primary hip replacement with cementless stem
Registration Number
NCT06632301
Lead Sponsor
Aesculap AG
Brief Summary

The goal of this interventional post-market follow-up study is to evaluate radiological changes in the diaphyseal bone density (Gruen Zones 3 and 4) within 24 months postoperative in patients treated with CoreHip® primary cementless stem. The DEXA bone density analysis is used.

Detailed Description

Additional diagnostic examination: DEXA-Analysis. A DEXA scan is an imaging test that measures bone density (strength). The results can provide helpful details about risk for osteoporosis (bone loss) and fractures. Furthermore we would like to find out more about stress shielding processes around our prosthesis.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Unilateral hip osteoarthritis
  • Indication for CoreHip Standard hip stem according to preoperative planning
  • Written Informed Consent
  • Age 35-85 years
  • According to the assessment of the study doctor, the patient is therapy compliant and able to attend the follow-up visits
Exclusion Criteria
  • Femoral neck fractures
  • Pregnancy
  • BMI > 35
  • History of femoral fracture or previous surgery on the same hip
  • Metabolic bone disease, use of steroids or other drugs affecting bone metabolism
  • Intraoperative bone cracks
  • Severe osteoarthritis of the contralateral hip
  • THA of the contralateral side or other event leading to restricted weight bearing during the study period

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
DEXAPrimary hip replacement with cementless stemDEXA bone density analysis to analyze the loading concept of the CoreHip® Prosthesis System
Primary Outcome Measures
NameTimeMethod
Radiological changes in the diaphyseal bone density (Gruen Zones 3 and 4)within 24 months postoperative

Changes in bone mineral density (BMD) according to Gruen.

Secondary Outcome Measures
NameTimeMethod
Development of Forgotten Joint Scorepreoperative, at discharge (1 week postop) and 12 months postoperative

The EQ-5D-5L score is a generic score used to document the well-being of the patient.

Clinical Results: Joint Function (Harris Hip Score)preoperative, at discharge (1 week postop) and 12 months postoperative

The functional results of the operated hip will be assessed with the Harris Hip Score (HHS) and evaluated over time.

Development of Quality of Life (EQ-5D-5L)preoperative, at discharge (1 week postop) and 12 months postoperative

The EQ-5D-5L score is a generic score used to document the well-being of the patient.

Development of Painpreoperative, at discharge (1 week postop) and 12 months postoperative

Radiological changes in the diaphyseal bone density (DEXA BMD progression over time in all Gruen Zones (Zone 1-7)

Trial Locations

Locations (1)

Medizinische Hochschule Hannover

🇩🇪

Hannover, Germany

© Copyright 2025. All Rights Reserved by MedPath